Princess Margaret Cancer Centre Innovation Acceleration Fund
The Princess Margaret Cancer Centre’s Innovation Acceleration Fund (IAF) has been established to overcome barriers to research translation. Its objective is to accelerate research discoveries made by Princess Margaret Cancer Centre researchers to demonstrate commercial applicability to potential industry partners.
A maximum of $250,000 is available per proposal. Eligible researchers affiliated with the Princess Margaret Cancer Centre can learn more here or by contacting Brian Bobechko, Business Development and Commercialization Principal at IAFinfo@tdc.uhnresearch.ca
Who can apply?
Are you a researcher at the Princess Margaret Cancer Centre? Think your project can accelerate cutting edge cancer research from bench to bedside? With the Innovation Acceleration Fund, early stage research with high commercialization potential receives critical funds to advance & help patients worldwide.
Learn more here.